Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC

被引：0
|
作者：
Heribert Hänscheid
Philipp E. Hartrampf
Andreas Schirbel
Andreas K. Buck
Constantin Lapa
机构：
[1] University Hospital Würzburg,Department of Nuclear Medicine
[2] University Hospital Augsburg,Department of Nuclear Medicine
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2021年 / 48卷
关键词：
DOTA-EB-TATE; Somatostatin receptor; Evans blue; Biokinetics; Intraindividual comparison;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2566 / 2572
页数：6
相关论文
共 50 条
  • [1] Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
    Haenscheid, Heribert
    Hartrampf, Philipp E.
    Schirbel, Andreas
    Buck, Andreas K.
    Lapa, Constantin
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (08) : 2566 - 2572
  • [2] Microfluidic synthesis of [177Lu]Lu-DOTA-TATE
    Liu, Zheng
    Schaap, Kevin
    Rohde, Martin
    Oehlke, Elisabeth
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2017, 60 : S462 - S462
  • [3] Re-treatment with [177Lu]Lu-DOTA-TATE or [177Lu]Lu-DOTA-TATE and [90Y]Y-DOTA-TATE of patients with progressive neuroendocrine neoplasm
    Durma, Adam Daniel
    Saracyn, Marek
    Kolodziej, Maciej
    Jozwik-Plebanek, Katarzyna
    Mroz, Adrianna
    Kapusta, Waldemar
    Dmochowska, Beata
    Kaminski, Grzegorz
    [J]. NUCLEAR MEDICINE REVIEW, 2023, 26 : 143 - 152
  • [4] Peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE
    Prado-Wohlwend, S.
    Bernal-Vergara, J. C.
    Utrera-Costero, A.
    Canon-Sanchez, J. R.
    Agudelo-Cifuentes, M.
    Bello-Arques, P.
    [J]. REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2022, 41 (01): : 55 - 65
  • [5] Clinical dosimetry of patients treated with Capecitabine, Temozolomide and [177Lu]Lu-DOTA-TOC combined therapy.
    Cichonski, A.
    Cwikla, J. B.
    Kolasinska-Cwikla, A.
    Kempinska-Wrobel, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S748 - S748
  • [6] Preventive measures and management of radiopharmaceutical extravasation with[177Lu]Lu-DOTA-TATE
    Eftychiou, N.
    Fernandez, R.
    Allen, S.
    Lewington, V.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S82 - S83
  • [7] In house labeling and characterization of 177Lu DOTA-TATE
    Yadav, Alok Kumar
    Meera, V
    Banerjee, Sharmila
    Malhotra, A.
    Bal, Chandarsekhar
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [8] Prediction of [177Lu]Lu-DOTA-TATE therapy response using the absorbed dose estimated from [177Lu]Lu-DOTA-TATE SPECT/CT in patients with metastatic neuroendocrine tumour
    Ha, Sejin
    Kim, Yong-il
    Oh, Jungsu S.
    Yoo, Changhoon
    Ryoo, Baek-Yeol
    Ryu, Jin-Sook
    [J]. EJNMMI PHYSICS, 2024, 11 (01)
  • [9] Prediction of [177Lu]Lu-DOTA-TATE therapy response using the absorbed dose estimated from [177Lu]Lu-DOTA-TATE SPECT/CT in patients with metastatic neuroendocrine tumour
    Sejin Ha
    Yong-il Kim
    Jungsu S. Oh
    Changhoon Yoo
    Baek-Yeol Ryoo
    Jin-Sook Ryu
    [J]. EJNMMI Physics, 11
  • [10] Results of individual patient dosimetry in peptide receptor radionuclide therapy with 177Lu DOTA-TATE and 177Lu DOTA-NOC
    Wehrmann, Christiane
    Senftleben, Stefan
    Zachert, Carolin
    Mueller, Dirk
    Baum, Richard P.
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2007, 22 (03) : 406 - 416
12345